Terms: = Breast cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
392 results:
1. Molecular and functional insight into anti-egfr nanobody: Theranostic implications for malignancies.
Tripathy RK; Pande AH
Life Sci; 2024 May; 345():122593. PubMed ID: 38554946
[TBL] [Abstract] [Full Text] [Related]
2. Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma.
Repici A; Ardizzone A; De Luca F; Colarossi L; Prestifilippo A; Pizzino G; Paterniti I; Esposito E; Capra AP
Cells; 2024 Feb; 13(4):. PubMed ID: 38391974
[TBL] [Abstract] [Full Text] [Related]
3. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
Fang Y; Zhang Q; Chen Z; Guo C; Wu J
Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
[TBL] [Abstract] [Full Text] [Related]
4. Research progress of good markers for canine mammary carcinoma.
Yang NY; Zheng HH; Yu C; Ye Y; Du CT; Xie GH
Mol Biol Rep; 2023 Dec; 50(12):10617-10625. PubMed ID: 37943402
[TBL] [Abstract] [Full Text] [Related]
5. ABERRANT METHYLATION OF cancer-RELATED GENES IN VIETNAMESE breast cancer PATIENTS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL FEATURES.
Dieu Vuong L; Ngoc Nguyen Q
Exp Oncol; 2023 Oct; 45(2):195-202. PubMed ID: 37824772
[TBL] [Abstract] [Full Text] [Related]
6. Profiling extracellular vesicle surface proteins with 10 µL peripheral plasma within 4 h.
He J; Li H; Mai J; Ke Y; Zhai C; Li JJ; Jiang L; Shen G; Ding X
J Extracell Vesicles; 2023 Sep; 12(9):e12364. PubMed ID: 37654045
[TBL] [Abstract] [Full Text] [Related]
7. Serum methylmalonic acid concentrations at breast cancer diagnosis significantly correlate with clinical frailty.
Wu Q; Hatse S; Kenis C; Fernández-García J; Altea-Manzano P; Billen J; Planque M; Vandekeere A; Lambrechts Y; Richard F; Punie K; Neven P; Smeets A; Nevelsteen I; Floris G; Desmedt C; Gomes AP; Fendt SM; Wildiers H
Geroscience; 2024 Apr; 46(2):1489-1498. PubMed ID: 37632634
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Value Of Basal Markers (Epidermal Growth Factor Receptor "egfr" And Cytokeratin 5/6) Expression In Triple-Negative Invasive breast cancer.
ElFeky AW; Saied EM; Shawky H; Sadaka E
J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S161-S166. PubMed ID: 37482851
[TBL] [Abstract] [Full Text] [Related]
9. Circegfr reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/egfr axis.
Ma J; Chen C; Fan Z; Zhang Y; Ji J; Wei D; Zhang F; Sun B; Huang P; Ren L
Int J Biol Macromol; 2023 Jul; 244():125295. PubMed ID: 37302631
[TBL] [Abstract] [Full Text] [Related]
10. Predictive markers for pathological complete response (pCR) after neo-adjuvant chemotherapy in HER2-positive breast carcinoma.
Van Bockstal MR; Dano H; Benhaddi N; Dubois D; Vanderveken J; Van Marcke C; Vandermeulen A; Duhoux FP; Vernaeve H; Berlière M; Galant C
Histol Histopathol; 2024 Feb; 39(2):153-164. PubMed ID: 37204204
[TBL] [Abstract] [Full Text] [Related]
11. Preliminary evaluation of deep learning for first-line diagnostic prediction of tumor mutational status.
Morel LO; Derangère V; Arnould L; Ladoire S; Vinçon N
Sci Rep; 2023 Apr; 13(1):6927. PubMed ID: 37117277
[TBL] [Abstract] [Full Text] [Related]
12. Ultrasensitive PEC cytosensor for breast cancer cells detection and inhibitor screening based on plum-branched CdS/Bi
Wang GQ; Ren XX; Wei JJ; Wang AJ; Zhao T; Feng JJ; Yun Cheang T
Bioelectrochemistry; 2023 Aug; 152():108442. PubMed ID: 37060704
[TBL] [Abstract] [Full Text] [Related]
13. The molecular landscape of breast mucoepidermoid carcinoma.
Venetis K; Sajjadi E; Ivanova M; Andaloro S; Pessina S; Zanetti C; Ranghiero A; Citelli G; Rossi C; Lucioni M; Malapelle U; Pagni F; Barberis M; Guerini-Rocco E; Viale G; Fusco N
Cancer Med; 2023 May; 12(9):10725-10737. PubMed ID: 36916425
[TBL] [Abstract] [Full Text] [Related]
14. [Targeting HER2 in colorectal cancer].
Spitzer E; Cervera P; André T; Cohen R
Bull Cancer; 2023 Apr; 110(4):402-411. PubMed ID: 36870811
[TBL] [Abstract] [Full Text] [Related]
15. egfr inhibitor-induced folliculitis decalvans: a case series and management guidelines.
Nowaczyk J; Fret K; Kaminska-Winciorek G; Rudnicka L; Czuwara J
Anticancer Drugs; 2023 Sep; 34(8):942-948. PubMed ID: 36708507
[TBL] [Abstract] [Full Text] [Related]
16. Identification of a novel peptide ligand for the cancer-specific receptor mutation egfrvIII using high-throughput sequencing of phage-selected peptides.
Mansour S; Adhya I; Lebleu C; Dumpati R; Rehan A; Chall S; Dai J; Errasti G; Delacroix T; Chakrabarti R
Sci Rep; 2022 Dec; 12(1):20725. PubMed ID: 36456600
[TBL] [Abstract] [Full Text] [Related]
17. Quantitative analysis of multiple breast cancer biomarkers using DNA-PAINT.
Chen Z; Yin G; Wei J; Qi T; Qian Z; Wang Z; Zong S; Cui Y
Anal Methods; 2022 Sep; 14(37):3671-3679. PubMed ID: 36063064
[TBL] [Abstract] [Full Text] [Related]
18. Aptamer-cocktail Functionalized Nano-microfluidic Chip for Enhancing Isolation and Characterization of Circulating cancer Cells.
Li M; Liu D; Zhang J; Zhang X; Dou X
Anticancer Res; 2022 Sep; 42(9):4345-4358. PubMed ID: 36039433
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of Clinicopathological Characteristics and Prognosis of Carcinosarcoma of the breast.
Tian Y; Liu X; Li Y; Meng Q; Jia Y; Wang B; He X
Breast J; 2022; 2022():3614979. PubMed ID: 35865143
[TBL] [Abstract] [Full Text] [Related]
20. Magnetic Resonance Imaging Features in diagnosis of breast cancer and Evaluation of Effect of Epidermal Growth Factor Receptor-Targeted Therapy.
Yang HH; Zhang FF
Biomed Res Int; 2022; 2022():3127058. PubMed ID: 35747502
[TBL] [Abstract] [Full Text] [Related]
[Next]
